[1]
Kinos, S., Hagman, H., Halonen, P., Soveri, L.-M., O’Reilly, M., Pfeiffer, P., Frödin, J.-E., Sorbye, H., Heervä, E., Liposits, G., Kallio, R., Ålgars, A., Ristamäki, R., Salminen, T., Bärlund, M., Shah, C.-H. , McDermott, R., Röckert, R., Flygare, P., Kwakman, J., Teske, A., Punt, C., Glimelius, B. and Österlund, P. 2024. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study). Acta Oncologica. 63, 1 (May 2024), 248–258. DOI:https://doi.org/10.2340/1651-226X.2024.24023.